Literature DB >> 17503325

Red-green color vision impairment in Duchenne muscular dystrophy.

Marcelo Fernandes Costa1, Andre Gustavo Fernandes Oliveira, Claudia Feitosa-Santana, Mayana Zatz, Dora Fix Ventura.   

Abstract

The present study evaluated the color vision of 44 patients with Duchenne muscular dystrophy (DMD) (mean age 14.8 years; SD 4.9) who were submitted to a battery of four different color tests: Cambridge Colour Test (CCT), Neitz Anomaloscope, Ishihara, and American Optical Hardy-Rand-Rittler (AO H-R-R). Patients were divided into two groups according to the region of deletion in the dystrophin gene: upstream of exon 30 (n=12) and downstream of exon 30 (n=32). The control group was composed of 70 age-matched healthy male subjects with no ophthalmological complaints. Of the patients with DMD, 47% (21/44) had a red-green color vision defect in the CCT, confirmed by the Neitz Anomaloscope with statistical agreement (P<.001). The Ishihara and the AO H-R-R had a lower capacity to detect color defects--5% and 7%, respectively, with no statistical similarity between the results of these two tests nor between CCT and Anomaloscope results (P>.05). Of the patients with deletion downstream of exon 30, 66% had a red-green color defect. No color defect was found in the patients with deletion upstream of exon 30. A negative correlation between the color thresholds and age was found for the controls and patients with DMD, suggesting a nonprogressive color defect. The percentage (66%) of patients with a red-green defect was significantly higher than the expected <10% for the normal male population (P<.001). In contrast, patients with DMD with deletion upstream of exon 30 had normal color vision. This color defect might be partially explained by a retina impairment related to dystrophin isoform Dp260.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17503325      PMCID: PMC1867095          DOI: 10.1086/518127

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  54 in total

Review 1.  Molecular genetics of color vision and color vision defects.

Authors:  M Neitz; J Neitz
Journal:  Arch Ophthalmol       Date:  2000-05

2.  ERG phenotype of a dystrophin mutation in heterozygous female carriers of Duchenne muscular dystrophy.

Authors:  K M Fitzgerald; G W Cibis; A H Gettel; R Rinaldi; D J Harris; R A White
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

3.  Localization of dystrophin and beta-dystroglycan in bovine retinal photoreceptor processes extending into the postsynaptic dendritic complex.

Authors:  F Schmitz; D Drenckhahn
Journal:  Histochem Cell Biol       Date:  1997-09       Impact factor: 4.304

4.  Electroretinogram in Duchenne/Becker muscular dystrophy.

Authors:  S I Pascual Pascual; J Molano; I Pascual-Castroviejo
Journal:  Pediatr Neurol       Date:  1998-04       Impact factor: 3.372

Review 5.  Dystrophin and muscular dystrophy: past, present, and future.

Authors:  K F O'Brien; L M Kunkel
Journal:  Mol Genet Metab       Date:  2001 Sep-Oct       Impact factor: 4.797

6.  Diagnosis of progressive muscular dystrophy.

Authors:  P J Vignos
Journal:  J Bone Joint Surg Am       Date:  1967-09       Impact factor: 5.284

Review 7.  Preterm birth and visual development.

Authors:  E E Birch; A R O'Connor
Journal:  Semin Neonatol       Date:  2001-12

Review 8.  Seeing with S cones.

Authors:  D J Calkins
Journal:  Prog Retin Eye Res       Date:  2001-05       Impact factor: 21.198

9.  Exon-intron organization of the human dystrophin gene.

Authors:  C Nobile; J Marchi; V Nigro; R G Roberts; G A Danieli
Journal:  Genomics       Date:  1997-10-15       Impact factor: 5.736

10.  A novel dystrophin isoform is required for normal retinal electrophysiology.

Authors:  V N D'Souza; T M Nguyen; G E Morris; W Karges; D A Pillers; P N Ray
Journal:  Hum Mol Genet       Date:  1995-05       Impact factor: 6.150

View more
  25 in total

1.  Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients.

Authors:  Tuy Nga Brignol; Patrice E Fort; Dora Fix Ventura; Ramin Tadayoni; Alvaro Rendon
Journal:  J AAPOS       Date:  2018-09-26       Impact factor: 1.220

2.  Current treatment and management of dystrophinopathies.

Authors:  Nathalie Goemans; Gunnar Buyse
Journal:  Curr Treat Options Neurol       Date:  2014-05       Impact factor: 3.598

3.  Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system.

Authors:  Valeria Ricotti; Herbert Jägle; Maria Theodorou; Anthony T Moore; Francesco Muntoni; Dorothy A Thompson
Journal:  Eur J Hum Genet       Date:  2015-06-17       Impact factor: 4.246

Review 4.  Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.

Authors:  Caroline Perronnet; Cyrille Vaillend
Journal:  J Biomed Biotechnol       Date:  2010-06-17

5.  Color discrimination in the tufted capuchin monkey, Sapajus spp.

Authors:  Paulo Roney Kilpp Goulart; Daniela Maria Oliveira Bonci; Olavo de Faria Galvão; Luiz Carlos de Lima Silveira; Dora Fix Ventura
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

6.  Molecular characterization of the 5'-UTR of retinal dystrophin reveals a cryptic intron that regulates translational activity.

Authors:  Ikuko Kubokawa; Yasuhiro Takeshima; Mitsunori Ota; Masahiro Enomoto; Yo Okizuka; Takeshi Mori; Noriyuki Nishimura; Hiroyuki Awano; Mariko Yagi; Masafumi Matsuo
Journal:  Mol Vis       Date:  2010-12-07       Impact factor: 2.367

7.  Profound human/mouse differences in alpha-dystrobrevin isoforms: a novel syntrophin-binding site and promoter missing in mouse and rat.

Authors:  Sabrina V Böhm; Panayiotis Constantinou; Sipin Tan; Hong Jin; Roland G Roberts
Journal:  BMC Biol       Date:  2009-12-04       Impact factor: 7.431

Review 8.  The roles of the dystrophin-associated glycoprotein complex at the synapse.

Authors:  Gonneke S K Pilgram; Saranyapin Potikanond; Richard A Baines; Lee G Fradkin; Jasprina N Noordermeer
Journal:  Mol Neurobiol       Date:  2009-11-09       Impact factor: 5.590

9.  Long-term occupational exposure to organic solvents affects color vision, contrast sensitivity and visual fields.

Authors:  Thiago Leiros Costa; Mirella Telles Salgueiro Barboni; Ana Laura de Araújo Moura; Daniela Maria Oliveira Bonci; Mirella Gualtieri; Luiz Carlos de Lima Silveira; Dora Fix Ventura
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

10.  Transcranial direct current stimulation modulates human color discrimination in a pathway-specific manner.

Authors:  Thiago L Costa; Balázs V Nagy; Mirella T S Barboni; Paulo S Boggio; Dora F Ventura
Journal:  Front Psychiatry       Date:  2012-09-12       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.